Valuation: ALTEOGEN Inc.

Market Cap 16,792B 11.12B 9.75B 9B 8.32B 15.77B 1,064B 16.08B 108B 42.04B 521B 41.74B 40.83B 1,808B P/E 2026 *
57.4x
P/E 2027 * 38.5x
Enterprise Value 16.29B 10.79M 9.46M 8.73M 8.07M 15.3M 1.03B 15.6M 105M 40.79M 505M 40.5M 39.61M 1.75B EV / Sales 2026 *
34.8x
EV / Sales 2027 * 23.8x
Free-Float
74.26%
Yield 2026 *
0.16%
Yield 2027 * 0.17%
1 day-7.11%
1 week-13.16%
Current month-13.16%
1 month-5.71%
3 months-11.44%
6 months-33.44%
Current year-30.26%
1 week 307,500
Extreme 307500
368,500
1 month 287,500
Extreme 287500
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-7.11%-13.16%-24.82%+712.18% 11.93B
-1.93%+6.00%+20.90%-5.85% 68.8B
-2.01%-3.57%+46.21%+217.06% 55.21B
-4.15%+36.30%+36.30%+36.30% 43.46B
+0.27%+8.33%-49.87%-53.43% 41.18B
-6.76%+2.96%+129.39%-39.36% 31.65B
-2.50%-4.80%+48.50%-29.09% 30.37B
-0.83%+2.66%+72.66%+88.79% 23.58B
-1.15%+8.29%+4.42%+184.96% 19.33B
-1.33%+1.11%+66.11%+131.83% 17.16B
Average -2.81%+2.29%+34.98%+124.34% 34.27B
Weighted average by Cap. -2.56%+3.04%+34.20%+73.71%

Financials

2026 *2027 *
Net sales 469B 310M 272M 251M 232M 440M 29.71B 449M 3.02B 1.17B 14.54B 1.17B 1.14B 50.47B 672B 445M 390M 360M 333M 631M 42.6B 644M 4.33B 1.68B 20.85B 1.67B 1.63B 72.37B
Net income 311B 206M 180M 167M 154M 292M 19.69B 298M 2B 778M 9.64B 772M 755M 33.45B 397B 263M 230M 213M 196M 372M 25.14B 380M 2.56B 993M 12.3B 986M 964M 42.7B
Net Debt -499B -330M -290M -267M -247M -468M -31.62B -478M -3.21B -1.25B -15.47B -1.24B -1.21B -53.71B -828B -548M -481M -444M -410M -777M -52.46B -793M -5.33B -2.07B -25.67B -2.06B -2.01B -89.12B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-07 313,500.00 -7.11% 452,829
26-07-07 ₩337,500.00 +1.96% 355,590
26-07-06 ₩331,000.00 -3.07% 266,040
26-07-03 ₩341,500.00 -2.84% 439,497
26-07-02 ₩351,500.00 -1.82% 392,958
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
337,500.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+35.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock